Article
Tivantinib induces mitotic death in SHH medulloblastoma cell lines.
2024-03-05
Abstract excerpt
The c-MET kinase signalling pathway is a key player in the development of the cerebellum and it has been identified as a potential therapeutic candidate for treating medulloblastoma. Here, we confirm that c-MET and its ligand HGF are highly expressed in the SHH medulloblastoma subgroup with SHH-α and SHH-β subtypes showing the highest levels of expression of both genes, respectively. HGF treatments and siRNA-media...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e64a78ee-1814-5773-9ab2-1f4bdfcebd61
- DOI
- 10.21203/rs.3.rs-3937528/v1
